As multiple genes of the PI3K/Akt/mTOR signaling pathway are frequently found mutated in cancer and interact with other crucial genes in oncogenesis, such as PTEN, they arguably constitute important therapeutic targets in the cancer therapeutic field [23,24]. The gene discussed is PTEN; the disease is cancer.